An Initial Evaluation of Human Plasma cMLC-1: A Potential Protein Biomarker for Trastuzumab-Induced Cardiotoxicity, Breast Cancer Screening and Progression.
Front Oncol
; 12: 809715, 2022.
Article
en En
| MEDLINE
| ID: mdl-35592673
Texto completo:
1
Base de datos:
MEDLINE
Tipo de estudio:
Diagnostic_studies
/
Prognostic_studies
/
Screening_studies
Idioma:
En
Revista:
Front Oncol
Año:
2022
Tipo del documento:
Article